B. Metzler Seel. Sohn & Co. Holding Ag United Therapeutics Corp Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in United Therapeutics Corp stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 960 shares of UTHR stock, worth $384,422. This represents 0.0% of its overall portfolio holdings.
Number of Shares
960Holding current value
$384,422% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
650Shares Held
45MCall Options Held
368KPut Options Held
414K-
Black Rock Inc. New York, NY5.47MShares$2.19 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.77 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.32 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.14 Billion12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$919 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $18.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...